October babies are more likely to develop the syndrome, according to a study presented at the Congress of the European Academy of Neurology (Amsterdam, The Netherlands).
Browsing: autoimmune diseases
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
Autoantibodies occur in many different nervous system disorders, and are increasingly being found in disorders not traditionally associated with the immune system. Determining if the autoantibodies play a functional or pathogenic role is critical in selecting the most appropriate treatment options.
Immune-brain relationships: new paradigms in searching for treatments for neurodegenerative disease?
A systemic immune network involving benign autoimmune T cells supports brain maintenance, function and repair, and could be boosted in a well-controlled manner for therapy of brain pathologies.
This Spotlight will explore every corner of neuroimmunology, looking in-depth at the history of the field, new uses for the immune system in a wealth of neurological diseases, and looking ahead at the future of this ever-expanding field.
In a computer-based study of response times, Crohn’s sufferers displayed an average cognitive function slower than that of healthy individuals.
A small clinical study has revealed a potential link between the Zika virus and autoimmune neurologic disorders in addition to concerns over microcephaly and Guillain-Barré syndrome.
Preclinical study demonstrates that multiple sclerosis nerve repair could be initiated by partial blockade of a cancer-promoting pathway, providing new hope for therapeutics.
Paul Matthews speaks to Ellen Clarke, Commissioning Editor: Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci is Head of the new Division of Brain Sciences at Imperial College, London.